跳至主要内容
临床试验/NCT03928691
NCT03928691Unknown不适用

Impact of Body Mass Index on Serum Maternal and Fetal Magnesium Level in Pregnant Recipients of Magnesium Sulphate

Assiut University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2019年6月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
400
试验地点
1
主要终点
the percentage of women reaching the Mg therapeutic level.

研究概览

简要总结

Magnesium sulphate is an inorganic salt with multiple therapeutic applications in medicine it has been widely utilized and studied on a diverse set of conditions such as asthma, cardiac arrhythmia and stroke. In pregnant women ,MgSo4 has been used in many cases such as for seizures prophylaxis in preeclampsia, tocolysis in preterm labour and for fetal neuroprotection in immenint preterm delivery.MgSo4 has been used as the standard drug for tocolysis in preterm labour and other drugs have been compared to it.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Study group

pregnant women admitted to Women's Health Hospital , Assiut university during 2019-2020 will be counseled to participate in the study

干预措施: Magnesium Sulfate (Drug)

结局指标

主要结局

the percentage of women reaching the Mg therapeutic level.

时间窗: 24 hours

the Mg therapeutic level of 4,8 mg/dl.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验